By analysing microbial profiles in three adipose tissue depots and the liver and plasma of morbidly obese individuals, a new study uncovers a unique organ-specific microbial signature, or potential internal ‘tissue microbiota’, in obese people with diabetes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Hotamisligil, G. S. Nature 444, 860–867 (2006).
Cani, P. D. et al. Diabetes 56, 1761–1772 (2007).
Cani, P. D. et al. Nat. Metab. 1, 34–46 (2019).
Udayappan, S. D. et al. PLoS One 12, e0181693 (2017).
Amar, J. et al. Diabetologia 54, 3055–3061 (2011).
Schierwagen, R. et al. Gut https://doi.org/10.1136/gutjnl-2019-319123 (2019).
Anhê, F. F. et al. Nat. Metab. https://doi.org/10.1038/s42255-020-0178-9 (2020).
Tilg, H., Zmora, N., Adolph, T. E. & Elinav, E. Nat. Rev. Immunol. 20, 40–54 (2020).
Cani, P. D. et al. Gut 58, 1091–1103 (2009).
Acknowledgements
P.D.C. is a senior research associate at Fonds de la Recherche Scientifique (FRS-FNRS), Belgium. He is supported by the Fonds Baillet Latour (Grant for Medical Research 2015), the Fondsde la Recherche Scientifique (FNRS, FRFS-WELBIO: WELBIO-CR-2019C-02R and EOS program no. 30770923).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.D.C. is an inventor in patent applications related to the use of Akkermansia muciniphila and its components in the context of obesity and related disorders. P.D.C. is also a co-founder of A-Mansia Biotech SA. M.V.H. declares no conflicts of interest.
Rights and permissions
About this article
Cite this article
Cani, P.D., Van Hul, M. Microbial signatures in metabolic tissues: a novel paradigm for obesity and diabetes?. Nat Metab 2, 211–212 (2020). https://doi.org/10.1038/s42255-020-0182-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-020-0182-0
This article is cited by
-
The gut microbiota in obesity and weight management: microbes as friends or foe?
Nature Reviews Endocrinology (2023)
-
Bacteroides ovatus-mediated CD27− MAIT cell activation is associated with obesity-related T2D progression
Cellular & Molecular Immunology (2022)
-
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Nature Metabolism (2021)